Market Overview:
The global β-thymidine market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The pharmaceutical grade segment is projected to account for the largest share of the global β-thymidine market in 2018. The industrial grade segment is projected to grow at a higher CAGR during the forecast period, owing to its growing demand from various end-use industries such as chemicals and others. North America accounted for the largest share of the global β-thymidine market in 2017 and it is expected to maintain its dominance throughout the forecast period.
 Industry Outlook.svg)
Product Definition:
β-Thymidine (CAS 50-89-5) is a nucleoside that has antiviral and immunostimulatory properties. It is used to prevent or treat viral infections, including HIV/AIDS, and to boost the immune system.
Pharmaceutical Grade:
Pharmaceutical grade is a term used for the products that are manufactured according to the standards set by pharmaceutical companies. These products are approved and recommended by drug regulatory bodies such as FDA, European Medicines Agency (EMA), China Food and Drug Administration (CFDA) etc.
Pharmaceutical-grade thymidine is a nucleoside analog used in the treatment of leukemia, lymphoma and myelodysplastic syndrome among others.
Industrial Grade:
Industrial grade is a type of specialty chemicals that are used in the production of thymidine. It is also used as an intermediate for the synthesis of pharmaceutical drugs and other chemical products. The global industrial-grade thymidine market size was valued at USD 8,859.1 thousand in 2016 and it is expected to grow at a CAGR of XX% over the forecast period on account increasing demand from pharmaceutical industries across the globe.
Application Insights:
The other application segment includes the use of β-thymidine in research activities and in chemical synthesis. The medicine segment dominated the global market accounting for a revenue share of over 60% in 2017. This is attributed to extensive usage as a drug for chemotherapy and radiotherapy treatment, particularly in cancer patients suffering from lung, breast or gastrointestinal tract cancer.
Chemical products are estimated to be one of the fastest growing segments with a CAGR exceeding 10% during the forecast period owing to increasing demand from various end uses such as pharmaceuticals and biotechnology companies. In addition, it is used extensively as an intermediate chemical which is further utilized within several industries such as oil & gas or food & beverage processing that contribute significantly towards regional economies worldwide.
Regional Analysis:
North America dominated the global market in terms of consumption and production. The region is expected to witness growth owing to increasing ‘off-label’ use of β-thymidine coupled with presence of major manufacturers such as Pfizer, Inc.; Merck Group; and Sanofi. In addition, high prevalence of cancer is also one of the factors responsible for its large share in the global market space.
Asia Pacific is anticipated to be one of the fastest growing regions due to rising healthcare spending by governments along with an increase in investment by multinational companies for R&D activities related to pharmaceuticals & biotechnology sector. Moreover, low cost labor availability along with favorable government policies are some other factors that can be attributed towards rapid growth experienced by this regional segment over past few years.
Growth Factors:
- Increasing demand from pharmaceutical and biotechnology industries for β-Thymidine as a key intermediate in the production of various drugs and therapies.
- Growing research and development activities for new applications of β-Thymidine in therapeutics, diagnostics, and medical research.
- Rising investments by manufacturers in expanding their production capacities to meet the growing demand for β-Thymidine globally.
- Increasing use of β-Thymidine in DNA sequencing and other molecular biology applications.
- Technological advancements that have led to improved methods of synthesizing β-Thymidine, making it more accessible and affordable to researchers and manufacturers worldwide
Scope Of The Report
Report Attributes
Report Details
Report Title
β-Thymidine (CAS 50-89-5) Market Research Report
By Type
Pharmaceutical Grade, Industrial Grade
By Application
Medicine, Chemical Products, Others
By Companies
Stereo Drugs, Zhejiang NHU, Hangzhou Neway Chemicals, Coben Pharmaceutical, Anhui Jintaiyang Pharmaceutical, Wuhan Fortuna Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global β-Thymidine (CAS 50-89-5) Market Report Segments:
The global β-Thymidine (CAS 50-89-5) market is segmented on the basis of:
Types
Pharmaceutical Grade, Industrial Grade
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medicine, Chemical Products, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stereo Drugs
- Zhejiang NHU
- Hangzhou Neway Chemicals
- Coben Pharmaceutical
- Anhui Jintaiyang Pharmaceutical
- Wuhan Fortuna Chemical
 Market Overview.svg)
Highlights of The β-Thymidine (CAS 50-89-5) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceutical Grade
- Industrial Grade
- By Application:
- Medicine
- Chemical Products
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the β-Thymidine (CAS 50-89-5) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
u00ceu00b2-Thymidine is a nucleoside analog that is used in the treatment of leukemia and other cancers.
Some of the key players operating in the î²-thymidine (cas 50-89-5) market are Stereo Drugs, Zhejiang NHU, Hangzhou Neway Chemicals, Coben Pharmaceutical, Anhui Jintaiyang Pharmaceutical, Wuhan Fortuna Chemical.
The ²-thymidine (cas 50-89-5) market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 β-Thymidine (CAS 50-89-5) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 β-Thymidine (CAS 50-89-5) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 β-Thymidine (CAS 50-89-5) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the β-Thymidine (CAS 50-89-5) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global β-Thymidine (CAS 50-89-5) Market Size & Forecast, 2018-2028
4.5.1 β-Thymidine (CAS 50-89-5) Market Size and Y-o-Y Growth
4.5.2 β-Thymidine (CAS 50-89-5) Market Absolute $ Opportunity
Chapter 5 Global β-Thymidine (CAS 50-89-5) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 β-Thymidine (CAS 50-89-5) Market Size Forecast by Type
5.2.1 Pharmaceutical Grade
5.2.2 Industrial Grade
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global β-Thymidine (CAS 50-89-5) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 β-Thymidine (CAS 50-89-5) Market Size Forecast by Applications
6.2.1 Medicine
6.2.2 Chemical Products
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global β-Thymidine (CAS 50-89-5) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 β-Thymidine (CAS 50-89-5) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America β-Thymidine (CAS 50-89-5) Analysis and Forecast
9.1 Introduction
9.2 North America β-Thymidine (CAS 50-89-5) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America β-Thymidine (CAS 50-89-5) Market Size Forecast by Type
9.6.1 Pharmaceutical Grade
9.6.2 Industrial Grade
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America β-Thymidine (CAS 50-89-5) Market Size Forecast by Applications
9.10.1 Medicine
9.10.2 Chemical Products
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe β-Thymidine (CAS 50-89-5) Analysis and Forecast
10.1 Introduction
10.2 Europe β-Thymidine (CAS 50-89-5) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe β-Thymidine (CAS 50-89-5) Market Size Forecast by Type
10.6.1 Pharmaceutical Grade
10.6.2 Industrial Grade
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe β-Thymidine (CAS 50-89-5) Market Size Forecast by Applications
10.10.1 Medicine
10.10.2 Chemical Products
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific β-Thymidine (CAS 50-89-5) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific β-Thymidine (CAS 50-89-5) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific β-Thymidine (CAS 50-89-5) Market Size Forecast by Type
11.6.1 Pharmaceutical Grade
11.6.2 Industrial Grade
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific β-Thymidine (CAS 50-89-5) Market Size Forecast by Applications
11.10.1 Medicine
11.10.2 Chemical Products
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America β-Thymidine (CAS 50-89-5) Analysis and Forecast
12.1 Introduction
12.2 Latin America β-Thymidine (CAS 50-89-5) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America β-Thymidine (CAS 50-89-5) Market Size Forecast by Type
12.6.1 Pharmaceutical Grade
12.6.2 Industrial Grade
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America β-Thymidine (CAS 50-89-5) Market Size Forecast by Applications
12.10.1 Medicine
12.10.2 Chemical Products
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) β-Thymidine (CAS 50-89-5) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) β-Thymidine (CAS 50-89-5) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) β-Thymidine (CAS 50-89-5) Market Size Forecast by Type
13.6.1 Pharmaceutical Grade
13.6.2 Industrial Grade
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) β-Thymidine (CAS 50-89-5) Market Size Forecast by Applications
13.10.1 Medicine
13.10.2 Chemical Products
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 β-Thymidine (CAS 50-89-5) Market: Competitive Dashboard
14.2 Global β-Thymidine (CAS 50-89-5) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stereo Drugs
14.3.2 Zhejiang NHU
14.3.3 Hangzhou Neway Chemicals
14.3.4 Coben Pharmaceutical
14.3.5 Anhui Jintaiyang Pharmaceutical
14.3.6 Wuhan Fortuna Chemical
